- LloydsPharmacy Clinical Homecare (LPCH) now cares for 100,000 patients across the UK – a milestone in supporting patients to undergo treatment in their own homes or communities.
- Forging more partnerships between clinical homecare and the NHS offers greater resilience for local hospitals, enabling them to spend time delivering urgent care, while maintaining the very highest standards of care for patients.
- LPCH continues to invest in new partnerships and innovation to deliver exceptional patient care.
LloydsPharmacy Clinical Homecare nurses, pharmacy teams and delivery drivers operate in high streets and homes across the country to meet the healthcare needs of their local communities.
LPCH offers patients the option to receive treatments for certain conditions closer to home. Working in partnership with the NHS, pharmaceutical companies and private health insurers to suit patient needs, the service allows for some treatments – treatments that do not need to be routinely managed in a hospital setting – to be carried out in the comfort and convenience of their home or local community.
From the delivery of specialist drugs direct to patients’ homes, to the administration of cancer treatments at home and in centres close to home, LPCH works in partnership with NHS consultants and nurses, medicines’ manufacturers, and patients and their carers to help people manage their conditions where they feel most comfortable.
Toby Anderson, CEO McKesson UK said:
“I am extremely proud that 100,000 patients are now receiving ongoing treatment closer to their home, supported by our LPCH nurses and support teams. LPCH helps patients with long-term and serious conditions to live more independent lives. More patients receiving their care through a clinical homecare pathway also means that local hospitals can concentrate on treating patients with acute and urgent conditions – something that is now more important than ever, as the NHS starts to recover from the Covid-19 pandemic. I want to thank all our colleagues in LPCH for their hard work, day in day out to support our patients”.
Over the last five years LPCH has seen significant growth in patient numbers, and now offers 28 different therapies and conditions, including cancer therapies, home parental nutrition, and enzyme replacement therapies.
LPCH is also investing in new innovations and partnerships to deliver the best patient care. Its partnership with Careology, is the first of its kind and enables clinicians, oncology nurses and carers to remotely monitor patients using digital technology. The platform empowers patients by providing access to their own medical statistics, and is designed to significantly enhance patient experience, improving the quality of care provided and the health outcomes of patients.
In April 2021 LPCH also began administering a new treatment for breast cancer in its Healthcare Centres. The treatment, Phesgo, will improve patient experience significantly, reducing the time they need to spend undergoing treatment from 150 minutes to just 30 minutes.
Patients remain the highest priority for LPCH. In the last patient satisfaction survey 89% of patients said they were either ‘extremely likely’ or ‘likely’ to recommend LPCH to friends and family if they needed similar care or treatment – a true testament to the value patients place on this treatment option.
Nick Davis, Operations Director, LPCH comments:
“Giving patients the option to choose clinical homecare as part of their treatment pathway offers convenience and flexibility, allowing patients to live more independently. Our fantastic colleagues deliver high-quality care in communities and at patients’ homes every day, and it is a testament to their work that we have now reached the 100,000-patient milestone. At LPCH, we are always working to innovate and improve the experience for our patients and their families. As we care for an increasing number of patients, we will continue to offer the very best care, and ensure we have a positive impact on their lives.”